Abstract

Acetaminophen is a widely used, nonprescription analgesic and antipyretic drug which can cause severe hepatic and renal cellular necrosis. Analysis of plasma and urinary concentrations of acetaminophen metabolites can facilitate an understanding of the relation of enzymatic pathways involved in the bioactivation and detoxification of acetaminophen to its cellular toxicity. There is a marked interindividual variability in the activity of these enzymatic pathways which play a critical role in the modulation of acetaminophen toxicity. A similar interindividual variability occurs in the in vivo temporal disposition of acetaminophen and its metabolites. Accordingly, optimal in vivo methods would permit repetitive sampling from the same animals, as opposed to sacrificing groups of different animals for each time point. This is particularly difficult in smaller rodents such as the mouse, where generally a single blood sample is obtained by cardiac puncture, often under conditions of general anesthesia which can affect drug metabolism and toxicity. A microvolumetric technique for repetitive blood sampling in individual mice, combined with a simple, high performance liquid chromatographic assay for acetaminophen and its toxicologically relevant metabolites is reported here. Data are presented for the disposition of acetaminophen and its metabolites in murine plasma, feces, and urine.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.